The effect of exercise on epigenetic modifications of PGC1: The impact on type 2 diabetes

Medical Hypotheses

Volumn 82, Issue 6, 2014, Pages 748-753

  Santos, Júlia M ^a,b   Tewari, Shikha ^c   Benite Ribeiro, Sandra A ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c DR Ram Manohar Lohia Institute of Medical Sciences Lucknow   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; INSULIN; INSULIN RECEPTOR; LYSINE; MESSENGER RNA; MYOCYTE ENHANCER FACTOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRIACYLGLYCEROL; DNA BINDING PROTEIN; PPARGC1A PROTEIN, HUMAN; SLC2A4RG PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

AEROBIC EXERCISE; ARTICLE; CALORIC INTAKE; CELL NUCLEUS; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; FAT INTAKE; GENE EXPRESSION; GLUCOSE TRANSPORT; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOTOXICITY; MITOCHONDRION; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PHYSICAL ACTIVITY; PROMOTER REGION; PROTEIN PROCESSING; SKELETAL MUSCLE; BIOLOGICAL MODEL; EXERCISE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; EXERCISE; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; MITOCHONDRIA; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; TRANSCRIPTION FACTORS;

EID: 84899647283     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.03.018     Document Type: Article

References (81)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
2. Chan J., Malik V., Jia W., Kadowaki T., Yajnik C.S., Yoon K.H., et al. Diabetes in Asia. JAMA 2009, 301:2129-2140.
3. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl. 1):S64-S71.
4. Viana L.V., Leitão C.B., Kramer C.K., Zucatti A.T.N., Jezini D.L., Felício J., et al. Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study. BMJ Open 2013, 3:e003336.
5. Chou C., Cotch M.F. Prevalence of nonrefractive visual. JAMA 2012, 308:2361-2368.
6. Santos J.M., Ribeiro S.B., Gaya A.R., Appell H.-J., Duarte J.A. Skeletal muscle pathways of contraction-enhanced glucose uptake. Int J Sports Med 2008, 29:785-794.
7. Santos J.M., Tewari S., Goldberg A.F.X., Kowluru R.A. Mitochondria biogenesis and the development of diabetic retinopathy. Free Radic Biol Med 2011, 51:1849-1860.
8. Dos Santos J.M., Benite-Ribeiro S.A., Queiroz G., Duarte J.A. The effect of age on glucose uptake and GLUT1 and GLUT4 expression in rat skeletal muscle. Cell Biochem Funct 2012, 30:191-197.
9. Karylowski O., Zeigerer A., Cohen A., Mcgraw T.E. GLUT4 is retained by an intracellular cycle of vesicle formation and fusion with endosomes. Mol Biol Cell 2004, 15:870-882.
10. Moller D. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414:821-827.
11. Jessen N., Goodyear L.J. Contraction signaling to glucose transport in skeletal muscle. J Appl Physiol 2005, 99:330-337.
12. Mu J., Brozinick J.T., Valladares O., Bucan M., Birnbaum M.J. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 2001, 7:1085-1094.
13. Musi N., Fujii N., Hirshman M.F., Ekberg I., Fro S., Ljungqvist O., et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001, 50:921-927.
14. Hayashi T., Wojtaszewski J.F.P., Goodyear L.J. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab 1997, 273:E1039-E1051.
15. Leng Y., Steiler T.L., Zierath J.R. Mitogen-activated protein kinase signaling in skeletal muscle from lean and ob/ob mice. Diabetes 2004, 53:1436-1444.
16. Tanti J.F., Grillo S., Grémeaux T., Coffer P.J., Van Obberghen E., Le Marchand-Brustel Y. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 1997, 138:2005-2010.
17. Wang Q., Somwar R., Bilan P.J., Liu Z., Jin J., Woodgett J.R., et al. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 1999, 19:4008-4018.
18. Imamura T., Huang J., Usui I., Satoh H., Bever J., Olefsky J.M. Involves protein kinase C-λ-mediated functional coupling between Rab4 and the motor protein kinesin insulin-induced GLUT4 translocation involves protein kinase C-λ- mediated functional coupling between Rab4 and the motor protein kinesin. Mol Cell Biol 2003, 23:4892-4900.
19. Sesti G., Federici M., Hribal M.L., Lauro D., Sbraccia P., Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 2001, 15:2099-2111.
20. Vollenweider P., Me B., Nicod P. Activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 2002, 51:1052-1059.
21. Pan D.A., Lillioja S., Kriketos A.D., Milner M.R., Baur L.A., Bogardus C., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997, 46:983-988.
22. Krssak M., Petersen K.F., Dresner A., Dipietro L., Vogel S.M., Rothman D.L., et al. Rapid communication Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study. Diabetologia 1999, 42:113-116.
23. Kraegen E.W., Clark P.W., Jenkins A.B., Daley E.A., Chisholm D.J., Storlien L.H. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991, 40:1397-1403.
24. Kelley D.E., Mokan M., Simoneau J.A., Mandarino L.J. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993, 92:91-98.
25. Boden G., Chen X., Ruiz J., White J.V., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994, 93:2438-2446.
26. Jucker B.M. 13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat. J Biol Chem 1997, 272:10464-10473.
27. Guo Z. Intramyocellular lipid kinetics and insulin resistance. Lipids Health Dis 2007, 6:18.
28. Aguirre V. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem 2000, 275:9047-9054.
29. Gao Z., Hwang D., Bataille F., Lefevre M., York D., Quon M.J., et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 2002, 277:48115-48121.
30. Moeschel K., Beck A., Weigert C., Lammers R., Kalbacher H., Voelter W., et al. Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1. J Biol Chem 2004, 279:25157-25163.
31. Rieusset J. Mitochondria and endoplasmic reticulum: mitochondria-endoplasmic reticulum interplay in type 2 diabetes pathophysiology. Int J Biochem Cell Biol 2011, 43:1257-1262.
32. Yan J., Feng Z., Liu J., Shen W., Wang Y., Wertz K., et al. Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate. J Nutr Biochem 2012, 23:716-724.
33. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and Type 2 diabetes. Mol Cell 2008, 9:367-377.
34. Holloszy J.O. Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr 2009, 89:463S-466S.
35. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008, 88:611-638.
36. Evans M.J., Scarpullas C. Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. J Biol Chem 1989, 264:14361-14368.
37. Piantadosi C.A., Suliman H.B. Mitochondrial transcription factor A induction by redox activation of nuclear respiratory factor 1. J Biol Chem 2006, 281:324-333.
38. Ohgaki K., Kanki T., Fukuoh A., Kurisaki H., Aoki Y., Ikeuchi M., et al. The C-terminal tail of mitochondrial transcription factor a markedly strengthens its general binding to DNA. J Biochem 2007, 141:201-211.
39. Czubryt M.P., McAnally J., Fishman G.I., Olson E.N. Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 2003, 100:1711-1716.
40. Lira V.A., Benton C.R., Yan Z., Bonen A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab 2010, 299:E145-E161.
41. Ringholm S., Olesen J., Pedersen J.T., Brandt C.T., Halling J.F., Hellsten Y., et al. Effect of lifelong resveratrol supplementation and exercise training on skeletal muscle oxidative capacity in aging mice; impact of PGC-1α. Exp Gerontol 2013, 48:1311-1318.
42. Scarpulla R.C. Metabolic control of mitochondial biogenesis trough the PCC-1 family regulatory network. Biochim Biophys Acta 2011, 1813:1269-1278.
43. Rytinki M.M., Palvimo J.J. SUMOylation attenuates the function of PGC-1alpha. J Biol Chem 2009, 284:26184-26193.
44. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273.
45. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003, 100:8466-8471.
46. Lelliott C.J., Medina-gomez G., Petrovic N., Kis A., Feldmann H.M., Bjursell M., et al. Ablation of PGC-1 b results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 2006, 4:e369.
47. Sonoda J., Mehl I.R., Chong L.-W., Nofsinger R.R., Evans R.M. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc Natl Acad Sci USA 2007, 104:5223-5228.
48. Jackson J.R., Ryan M.J., Alway S.E. Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J Gerontol A Biol Sci Med Sci 2011, 66:751-764.
49. Muoio D.M., Koves T.R. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab 2007, 32:874-883.
50. Santos J.M., Mohammad G., Zhong Q., Kowluru R.A. Diabetic retinopathy, superoxide damage and antioxidants. Curr Pharm Biotechnol 2011, 12:352-361.
51. Zhong Q., Kowluru R.A. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 2013, 62:2559-2568.
52. Galmozzi A., Mitro N., Ferrari A., Gers E., Gilardi F., Godio C., et al. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 2013, 62:732-742.
53. Portela A., Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010, 28:1057-1068.
54. Santos J.M., Kowluru R.A. Impaired transport of mitochondrial transcription factor A (TFAM) and the metabolic memory phenomenon associated with the progression of diabetic retinopathy. Diabetes Metab Res Rev 2013, 29:204-213.
55. Bird A. Perceptions of epigenetics. Nature 2007, 447:396-398.
56. Kowluru R.A., Santos J.M., Mishra M. Epigenetic modifications and diabetic retinopathy. Biomed Res Int 2013, [epub ahead of print].
57. Pooya S., Blaise S., Moreno Garcia M., Giudicelli J., Alberto J.M., Guéant-Rodriguez R.M., et al. Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hypomethylation and decreased ER-α, ERR-α, and HNF-4α in the rat liver. J Hepatol 2012, 57:344-351.
58. Garcia M.M., Guéant-Rodriguez R.M., Pooya S., Brachet P., Alberto J.M., Jeannesson E., et al. Methyl donor deficiency induces cardiomyopathy through altered methylation/acetylation of PGC-1α by PRMT1 and SIRT1. J Pathol 2011, 225:324-335.
59. Barrès R., Osler M.E., Yan J., Rune A., Fritz T., Caidahl K., et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 2009, 10:189-198.
60. Brøns C., Jacobsen S., Nilsson E., Rönn T., Jensen C.B., Storgaard H., et al. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab 2010, 95:3048-3056.
61. Alibegovic A.C., Sonne M.P., Højbjerre L., Bork-Jensen J., Jacobsen S., Nilsson E., et al. Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. Am J Physiol Endocrinol Metab 2010, 299:E752-E763.
62. Ribel-Madsen R., Fraga M.F., Jacobsen S., Bork-Jensen J., Lara E., Calvanese V., et al. Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS One 2012, 7:e51302.
63. Raichur S., Teh S.H., Ohwaki K., Gaur V., Long Y.C., Hargreaves M., et al. Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells. J Mol Endocrinol 2012, 49:203-211.
64. Benite-Ribeiro S.A., Dos Santos J.M., Duarte J.A.R. Moderate physical exercise attenuates the alterations of feeding behaviour induced by social stress in female rats. Cell Biochem Funct 2014, 32:142-149.
65. Wheatley C.M., Rattigan S., Richards S.M., Barrett E.J., Clark M.G. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats. Am J Physiol Endocrinol Metab 2004, 287:E804-E809.
66. Wright D.C. Mechanisms of calcium-induced mitochondrial biogenesis and GLUT4 synthesis. Appl Physiol Nutr Metab 2007, 32:840-845.
67. Michael L.F., Wu Z., Cheatham R.B., Puigserver P., Adelmant G., Lehman J.J., et al. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc Natl Acad Sci USA 2001, 98:3820-3825.
68. Baar K., Wende A.R., Jones T.E., Marison M., Nolte L.A., et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB 2002, 16:1879-1886.
69. Short K.R., Vittone J.L., Bigelow M.L., Proctor D.N., Rizza R.A., Coenen-Schimke J.M., et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003, 52:1888-1896.
70. Little J.P., Safdar A., Wilkin G.P., Tarnopolsky M.A., Gibala M.J. A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms. J Physiol 2010, 588:1011-1022.
71. Ikeda S., Kawamoto H., Kasaoka K., Hitomi Y., Kizaki T., Sankai Y., et al. Muscle type-specific response of PGC-1 alpha and oxidative enzymes during voluntary wheel running in mouse skeletal muscle. Acta Physiol 2006, 188:217-223.
72. Leick L., Fentz J., Biensø R.S., Knudsen J.G., Jeppesen J., Kiens B., et al. PGC-1{alpha} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2010, 299:E456-E465.
73. Potthoff M.J., Wu H., Arnold M.A., Shelton J.M., Backs J., McAnally J., et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 2007, 117:2459-2467.
74. Miura S., Kai Y., Ono M., Ezaki O. Overexpression of peroxisome proliferator-activated receptor gamma coactivator-1alpha down-regulates GLUT4 mRNA in skeletal muscles. J Biol Chem 2003, 278:31385-31390.
75. Benton C.R., Holloway G.P., Han X.-X., Yoshida Y., Snook L.A., Lally J., et al. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia 2010, 53:2008-2019.
76. Barrès R., Yan J., Egan B., Treebak J.T., Rasmussen M., Fritz T., et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 2012, 15:405-411.
77. McGee S.L., Fairlie E., Garnham A.P., Hargreaves M. Exercise-induced histone modifications in human skeletal muscle. J Physiol 2009, 15:5951-5958.
78. Ntanasis-Stathopoulos J., Tzanninis J.G., Philippou A., Koutsilieris M. Epigenetic regulation on gene expression induced by physical exercise. J Musculoskelet Neuronal Interact 2013, 13:133-146.
79. McGee S.L., Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms. Clin Exp Pharmacol Physiol 2006, 33:395-399.
80. Vissing K., Anderson J.L., Harridge S.D.R., Sandri C., Hartkopp A., Kjaer M., et al. Gene expression of myogenic factors and phenotype-specific markers in electrically stimulated muscle of paraplegics. J Appl Physiol 2005, 99:164-172.
81. Smith J.A.H., Kohn T.A., Chetty A.K., Ojuka E.O. CaMK activation during exercise is required for histone hyperacetylation and MEF2A binding at the MEF2 site on the Glut4 gene. Am J Physiol Endocrinol Metab 2008, 295:E698-E704.